P5

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 06 Feb 2025 filing date already counts against anyone who files later.

Record

Serial number

79418922

Mark type

Stylized text

Filed

06 Feb 2025

Published for opposition

10 Mar 2026

Attorney of record

Ryan D. Artis

Goods and services

• Class 001 — Chemicals: Chemical, biochemical, biological, and biotechnological preparations, in particular, antibodies, fragments of antibodies and antibody-drug conjugates for industrial and scientific use; antibodies, fragments of antibodies and antibody-drug conjugates for the development or manufacture of therapeutic reagents for industrial and scientific use; biological preparations, in particular, antibodies, fragments of antibodies and antibody-drug conjugates for laboratories, diagnostics and analytics for scientific or research use; chemical, biochemical, biological, and biotechnological preparations for industrial and scientific use.
• Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations and substances for the treatment of cancer, inflammatory diseases, autoimmune diseases, infective diseases, cardiovascular diseases, liver metabolic disorders and other conditions which can be treated or ameliorated by antibodies binding to, or activation or blocking of, a target antigen; therapeutic pharmaceuticals, namely antibody-drug conjugates for the treatment of cancer and autoimmune diseases; pharmaceutical and veterinary preparations for the treatment of cancer, inflammatory diseases, autoimmune diseases, infective diseases, cardiovascular diseases and liver metabolic disorders comprising small molecules; small molecule compounds being pharmaceuticals for the treatment of cancer
• Class 042 — Scientific and technological services: Scientific and technological services, namely scientific research, analysis, testing and design in the fields of biology, chemistry and medicine, as well as in the fields of immunology, oncology, molecular biology, cellular biology, biochemistry and medicinal chemistry as well as in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, diagnostic preparations, biomarker reagents and diagnostic apparatus​​​​​​​

Owner

• Tubulis GmbH, DE
• Tubulis GmbH, DE

Prosecution history

• 10 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 10 Mar 2026 — PUBLISHED FOR OPPOSITION
• 04 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 13 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 13 Feb 2026 — EXAMINER'S AMENDMENT ENTERED
• 13 Feb 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 13 Feb 2026 — EXAMINERS AMENDMENT E-MAILED
• 13 Feb 2026 — EXAMINERS AMENDMENT -WRITTEN
• 04 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 04 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 04 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 05 Sept 2025 — REFUSAL PROCESSED BY IB
• 21 Aug 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
• 20 Aug 2025 — REFUSAL PROCESSED BY MPU
• 17 Jul 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW